Puzzles, card games later in life may delay Alzheimer’s onset by five years, study finds

Playing puzzles, card games, reading books and engaging in other mentally stimulating activities later in life can help delay the onset of Alzheimer’s dementia by five years, researchers found. Findings…

Panel says Biogen’s Aduhelm Alzheimer’s drug shows no benefit

Check out what’s clicking on FoxBusiness.com. An expert panel unanimously voted that Biogen’s controversial Alzheimer’s drug does not provide more benefit to patients than supportive care. The latest blow dealt…

Cleveland Clinic won’t carry controversial Alzheimer’s drug

The Cleveland Clinic said it will not carry Biogen’s controversial Alzheimer’s drug after a panel of experts “reviewed all available scientific evidence on this medication.” The clinic, one of the…

FDA chief calls for investigation into Biogen Alzheimer’s drug approval process

T3 Trading chief strategist Scott Redler gives his market outlook on biotech investing. The acting commissioner of the Food and Drug Administration (FDA), Janet Woodcock, is calling for an investigation…

Does new Alzheimer’s drug work? Answers may miss 2030 target

When a controversial Alzheimer’s drug won U.S. approval, surprise over the decision quickly turned to shock at how long it might take to find out if it really works —…

Costly new Alzheimer’s drug could force Medicare to restrict access

T3 Trading chief strategist Scott Redler gives his market outlook on biotech investing. The recent approval of a high-price Alzheimer’s drug is raising questions about who will have access to…

Alzheimer’s drug stirs hope for patients, worry for doctors

What is Alzheimer’s disease? Alzheimer’s Association Chief Scientific Officer Dr. Maria Carrillo explains what Alzheimer’s disease is and how much it costs the U.S. health care system. In the weeks…

Eli Lilly’s Alzheimer’s drug gets FDA Breakthrough Therapy designation

Strategic Wealth Partners President and CEO Mark Tepper and former Trump economic adviser Steve Moore discuss how the markets will react to a Fed rate hike and tapering Eli Lilly…

FDA approved Biogen Alzheimer’s drug despite some staff concerns

Check out what’s clicking on FoxBusiness.com. The U.S. Food and Drug Administration approved the first new Alzheimer’s drug in decades over the objection of agency statisticians who said there was…

FDA adviser who resigned over Alzheimer’s drug says ‘no good evidence’ it works

One of the FDA advisory panel members who resigned after the agency granted Biogen’s Alzheimer’s drug Accelerated Approval has said “the drug showed no good evidence that it worked.” Dr.…